Pharmaceutical and biotechnology companies are increasing dependence on CROs as a way to improve drug development due to rising costs of R toxicology studies; pharmacokinetic and bioanalytical testing in accordance with Good Laboratory Practice (GLP). During the clinical phase, CROs manage trial design, site selection, patient recruitment, data management/biostatistics, monitoring, and regulatory documentation in accordance with Good Clinical Practice (GCP). Because CROs have a global presence, they can help conduct multinational clinical trials, which result in a more diverse pool of patients when recruiting subjects for multicentered studies, and ensure that the studies are conducted in compliance with the regulatory standards set forth by USFDA, EMA, and CDSCO. CROs (Clinical Research Organizations) can provide many benefits for pharmaceutical companies, including lowering expenses, sharing risks, having flexibility with resources, getting expertise from around the world, and being more efficient in operations. CRO's offer significant advantages to small/medium-size pharma companies that might not have all the resources needed to conduct large-scale studies and clinical trials on their own. CROs also support with regulatory submissions, quality assurance audits, medical writing, and post-marketing surveillance and provide assistance in meeting the regulatory requirements and ensure patient safety. There are some challenges that are associated with outsourcing to CROs, such as the risk of breach of data confidentiality, issues regarding the quality control of the work that is performed by the CROs, poor communication between companies and CROs and reliance on a third-party to conduct part of your business. For these reasons, good collaboration with the CRO, well-written contracts, and strong oversight are critical to achieving your project goals. Overall, CROs have become a vital partner in the development of today's drugs. By combining science innovation, regulatory expertise, and global operational capability, CROs greatly reduce the time required for drug development, help to lower costs, and increase the overall effectiveness of bringing safe and effective drugs into the marketplace. CROs have evolved in response to the changing landscape of the pharmaceutical industry as it moves towards a more collaborative, outsourced, and digitally driven research environment.
Yadav et al. (Thu,) studied this question.